Clinical Trial Update: Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous [Phase 1, Phase 2]

View source ↗

Summary

A pilot Phase 1/2 clinical trial evaluating the effect of clopidogrel on plasmatic soluble CD40 ligand in systemic lupus erythematosus; the study status is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Systemic Lupus Erythematous | Phase 1, Phase 2 | Status: COMPLETED